Medical Treatment of Cerebral Infarction

  • Jiro Suzuki


In the treatment of cerebral infarction, it is of course important to distinguish between the prevention and the treatment of the underlying lesions which give rise to cerebral infarction, but in clinical practice the basis for treatment normally focuses on two problems: how to minimize cerebral edema and how to prevent progression of the lesion to a state of infarction. For these purposes, various drug therapies have been developed, but there are as yet few techniques which have been shown to be theoretically and experimentally sound and clinically effective. In practice, it is therefore necessary first to come to a sufficient understanding of the changing cerebral pathology of each patient, and then to undertake control of blood pressure, cerebral edema, etc., in order to maintain appropriate cerebral blood flow and control of the patient's systemic condition.


Cerebral Infarction Cerebral Edema Acute Stage Ergot Alkaloid Cerebral Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Acheson J (1971): Factors affecting the natural history of focal cerebral vascular disease. Q J Med 40: 25–46PubMedGoogle Scholar
  2. 2.
    Baker RN, Broward JH, pang HC et al (1962): Anticoagulant therapy in cerebral infarction: report of a co-operative study. Neurology (Minneap) 12: 823–835Google Scholar
  3. 3.
    Baskin DS, Hosobuchi Y (1981): Naloxone reversal of ischemic neurological deficits in man. Lancet 2: 272–275PubMedCrossRefGoogle Scholar
  4. 4.
    Beevers DG, Fairman MJ, Hamilton M et al (1973): Antihypertensive treatment and the course of established cerebral disease. Lancet 1: 1407–1409PubMedCrossRefGoogle Scholar
  5. Bousser MG, Eschwege E, Hauenau M et al (1983) AICLA“controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 14: 5–14PubMedCrossRefGoogle Scholar
  6. 6.
    Canadian Cooperative Study Group (1978): A randomized trial of aspirin and sul-flnphrazone in threatened stroke. N Engl J Med 299: 53–59CrossRefGoogle Scholar
  7. 7.
    Carter AB (1961): Anticoagulant treatment in progressing stroke. Br Med J 52: 70–73CrossRefGoogle Scholar
  8. 8.
    Carter AB (1970): Hypotensive therapy in stroke survivors. Lancet 1: 485–489PubMedCrossRefGoogle Scholar
  9. 9.
    Dyken M, White PT (1956): Evaluation of cortisone in treatment of cerebral infarction. JAMA 162: 1531–1534CrossRefGoogle Scholar
  10. 10.
    Fields W, Lemak NA, Frankowski RF et al (1977): Controlled trial of aspirin in cerebral ischemia. Stroke 8: 301–316PubMedCrossRefGoogle Scholar
  11. 11.
    Fisher CM (1982): Management of occlusive cerebrovascular disease. In: Ropper AH, Kennedy SK et al (eds) Neurological and neurosurgical intensive care. University Park Press, Baltimore, pp 189–205Google Scholar
  12. 12.
    Fletcher AP, Alkjaersig N, Lewis M et al (1976): A pilot study of urokinase therapy in cerebral infarction. Stroke 7: 135–142PubMedCrossRefGoogle Scholar
  13. 13.
    Harter HR, Burch N, Majerus PW et al (1979): Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 301: 577–579PubMedCrossRefGoogle Scholar
  14. 14.
    Heck AF (1984): Medical management of TIAs and small strokes. In: Smith RR (ed): Stroke and the extracranial vessels. Raven Press, New York’ pp 149–158Google Scholar
  15. 15.
    Hutchinson EC (1983): Management of cerebral infarction. In: Russel RWR (ed) Vascular disease of the central nervous system, edn 2, Churchill Livingstone, Edinburgh London Melbourne New York, pp 185–203Google Scholar
  16. 16.
    Genton E, Barnett HJM, Fields WS et al (1977): Cerebral ischemia: The role of thrombosis and of antithrombotic therapy. Stroke 8: 150–175PubMedCrossRefGoogle Scholar
  17. 17.
    Katzman R, Clasen R, Klatzo I et al (1977): Brain edema in stroke. Stroke 8: 512–540PubMedCrossRefGoogle Scholar
  18. 18.
    Kuriyama Y, Sawada T, Yamaguchi T et al (1980): Induced hemodilution in acute stage of cerebral infarction, its pathophysiological and therapeutic consideration. Jpn J Stroke 2: 309–315 (Eng Abstr)CrossRefGoogle Scholar
  19. 19.
    Matthews WB, Oxbury JM, Grainger KMR et al (1976): A blind controlled trial of dextran 40 in the treatment of ischemic stroke. Brain 99: 193–206PubMedCrossRefGoogle Scholar
  20. 20.
    Meyer JS, Charney JZ, Mathew NT (1971): Treatment with glycerol of cerebral edema due to acute cerebral infarction. Lancet 2: 993–997PubMedCrossRefGoogle Scholar
  21. 21.
    Meyer JS, Fukuuchi Y, Shimazu J et al (1972): Effect of intravenous infusion of glycerol on hemispheric blood flow and metabolism in patients with acute cerebral infarction. Stroke 3: 167–180Google Scholar
  22. 22.
    Meyer JS, Gilroy JG, Barnhart MI et al (1963): Therapeutic thrombosis in cerebral thromboembolism. Neurology 13: 927–937PubMedGoogle Scholar
  23. 23.
    Millikan CH (1971): Reassessment of anticoagulant therapy in various types of occlusive cerebrovascular disease. Stroke 2: 201–208PubMedCrossRefGoogle Scholar
  24. 24.
    Minematsu K, Yamaguchi T, Kuryama Y et al (1983): Clinical application of barbiturate therapy for cerebral infarction: a preliminary report. Jpn J Stroke 5: 286–294CrossRefGoogle Scholar
  25. 25.
    Mizoi M, Oba M, Fujimoto S et al (1984): An experimental study on the protective effect of nizofenone in cerebral ischemia. No To Shinkei 36: 1089–1093PubMedGoogle Scholar
  26. 26.
    Mulley G, Wilcox RG, Mitchell JRA (1978): Dexamethasone in acute stroke. Br Med J 2: 994–996PubMedCrossRefGoogle Scholar
  27. 27.
    Patten BM, Mendell J, Bruun B et al (1972): Doubleblind study of the effects of dexamethasone on acute stroke. Neurology 22: 337–383Google Scholar
  28. 28.
    Rockoff MA, Marshall LF, Shapiro HM (1979): High-dose barbiturate therapy in humans: a clinical review of 60 patients. Ann Neurol 6: 194–199PubMedCrossRefGoogle Scholar
  29. 29.
    Sandok BA, Furlan AJ, Whisnant JP et al (1978): Guidelines for the management of transient ischemic attacks. Mayo Clin Proc 53: 665–674PubMedGoogle Scholar
  30. 30.
    Satake K, Kondo H, Fukase M (1979): A double-blind study on the clinical efficacy of urokinase in treatment of patients with cerebral infarction. In: Yamori et al (eds) Prophylactic approach to hypertensive disease. Perspective in Cardiovascular Reseach 4: 433–440Google Scholar
  31. 31.
    Smith AL, Hoff JT, Nielsen SL et al (1974) Barbiturate protection in acute focal cerebral ischemia. Stroke 5: 1–5PubMedCrossRefGoogle Scholar
  32. 32.
    Smith AL (1977) Barbiturate protection in cerebral hypoxia. Anesthesiology 47: 285–293PubMedCrossRefGoogle Scholar
  33. 33.
    Sorensen PS, Pedersen H, Marquardsen J et al (1983) Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks: a Danich cooperative study. Stroke 14: 15–22PubMedCrossRefGoogle Scholar
  34. 34.
    Suzuki J, Fujimoto S, Mizoi K et al (1984) The protective effect of combined administration of anti-oxidants and perfluorochemicals on cerebral ischemia. Stroke 15: 672–679PubMedCrossRefGoogle Scholar
  35. 35.
    Suzuki TA, Yoshimoto T et al (1985) Use of balloon occlusion and substances to protect ischemic brain during resection of posterior fossa AVM: case report. J Neurosurg 63: 626–629PubMedCrossRefGoogle Scholar
  36. 36.
    Tamura A, Asano T, Sano K et al (1979) Protection from cerebral ischemia by a new imidazole derivative (Y-9179) and pentobarbital: a comparative study in chronic MCA occlusion in cats. Stroke 10: 126–134PubMedCrossRefGoogle Scholar
  37. 37.
    Yatsu FM, Diamond I, Graziano C et al (1972) Experimental brain ischemia: protection from irreversible damage with a rapid-acting barbiturate (methohexital). Stroke 3: 726–732PubMedCrossRefGoogle Scholar
  38. 38.
    Yatsu FM (1975) Protective effects of barbiturates on cerebral ischemia. In: McLaurin RL (ed) Head injuries, 2nd Chicago Symposium on Neural Trauma. Grune and Stratton, New York, pp 185–187Google Scholar
  39. 39.
    Yatsu FM (1984) Medical management of complete strokes. In: Smith RR (ed) Stroke and the extracranial vessels. Raven Press, New York, pp 159–166Google Scholar
  40. 40.
    Whisnant JP, Matsumoto N, Elveback LR (1973) The effect of anticoagulation therapy on the prognosis of patients with transient cerebral ischemic attacks in a community: Rochester, Minnesota 1955 through 1969. Mayo Clin Proc 48: 844–848PubMedGoogle Scholar
  41. 41.
    Wise BL, Chater N (1962) The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebrospinal fluid pressure. J Neurosurg 19: 1038–1043PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1987

Authors and Affiliations

  • Jiro Suzuki
    • 1
  1. 1.Division of Neurosurgery, Institute for Brain DiseasesTohoku University School of MedicineNagamachi, SendaiJapan

Personalised recommendations